Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]
NYS Entity Status
NYS Filing Date
JANUARY 18, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC PROFESSIONAL SERVICE LIMITED LIABILITY COMPANY
2013 - MATTEO CHIROPRACTIC & PHYSICAL THERAPY, PLLC
AROUND THE WEB
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
- SetPoint Nabs $30M For More Tests of Bioelectric Device as RA Therapy
By Frank Vinluan - Monday Aug 28, 2017
SetPoint Medical is trying to use tiny pulses of electricity to treat inflammation in the body, and it now has an additional $30 million in funding to continue testing its approach in humans. The capital infusion announced Monday for SetPoint is a Series D round of investment. The company says it plans to use the […]
- Affording Alternative Medicine
By Barry Bridges - Friday Jun 2, 2017
Every year, Americans pay billions of dollars for complementary, alternative and integrative health care — chiropractic adjustments, acupuncture, massage therapy, biofeedback and more. But with very few exceptions, insurance policies typically don’t cover these treatments. Alternative medicine accounts for as much as 11.2% of total out-of-pocket spending on health care. Despite its popularity, insurers tend to view this type of care as untested, experimental or scientifically at odds with mainstream medicine. It’s one of the more glaring disconnects in American ...
- TheraGun Putting Vibration Therapy in Hands Of Players
By Tim Newcomb - Thursday Sep 14, 2017
As players continue to search for ways to ease the strain on their body, TheraGun points them toward vibration therapy.
The post TheraGun Putting Vibration Therapy in Hands Of Players appeared first on BaseballAmerica.com.
- Illumina Accelerator Sees ‘Huge Impact in Genomics’ in New Startups
By David Holley - Wednesday Jul 26, 2017
Genomics startups are increasing in number and quality, so much so that three-year-old Illumina Accelerator has expanded with its latest class to accommodate five of them. Xconomy got an early look at the specialty accelerator’s sixth cohort, which includes a company named for a butterfly and the accelerator’s first digital health startup. Illumina (NASDAQ: ILMN), […]